Keyphrases
Clinical Application
100%
Prostate-specific Antigen
100%
Small Molecules
100%
Positron Emission Tomography
100%
Radiotracer
100%
Prostate Cancer
33%
Patient Management
16%
Malignancy
16%
Clinical Setting
16%
Radionuclides
16%
Small Molecule Inhibitors
16%
Standard of Care
16%
High-grade Prostate Cancer
16%
Definitive Therapy
16%
High Sensitivity
16%
High Specificity
16%
Clinical Standards
16%
Widespread Adoption
16%
Biochemical Recurrence
16%
Targeted Agents
16%
De-facto
16%
Tumor Neovasculature
16%
Preclinical Development
16%
Prostate Cancer Imaging
16%
Anti-metastasis
16%
Oligometastatic Disease
16%
Oligorecurrent
16%
Medicine and Dentistry
Positron Emission Tomography
100%
Radioactive Tracer
100%
Prostate Specific Membrane Antigen
100%
Prostate Cancer
66%
Malignant Neoplasm
33%
Disease
16%
Neoplasm
16%
Cancer
16%
Radioisotope
16%
Patient Care
16%
Sensitivity and Specificity
16%
Metastatic Carcinoma
16%
Biochemical Recurrence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tracer
100%
Prostate Specific Membrane Antigen
100%
Prostate Cancer
66%
Malignant Neoplasm
33%
Disease
16%
Neoplasm
16%
Biochemical Recurrence
16%
Radioisotope
16%
Neuroscience
Positron Emission Tomography
100%
Prostate Specific Membrane Antigen
100%
Prostate
66%